Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 126

1.

Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III.

Marggraf MB, Panteleev PV, Emelianova AA, Sorokin MI, Bolosov IA, Buzdin AA, Kuzmin DV, Ovchinnikova TV.

Mar Drugs. 2018 Nov 26;16(12). pii: E466. doi: 10.3390/md16120466.

2.

Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling.

Shtam T, Naryzhny S, Samsonov R, Karasik D, Mizgirev I, Kopylov A, Petrenko E, Zabrodskaya Y, Kamyshinsky R, Nikitin D, Sorokin M, Buzdin A, Gil-Henn H, Malek A.

Breast Cancer Res Treat. 2018 Nov 27. doi: 10.1007/s10549-018-5043-0. [Epub ahead of print]

PMID:
30484103
3.

Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data.

Sorokin M, Kholodenko R, Suntsova M, Malakhova G, Garazha A, Kholodenko I, Poddubskaya E, Lantsov D, Stilidi I, Arhiri P, Osipov A, Buzdin A.

Cancers (Basel). 2018 Sep 29;10(10). pii: E365. doi: 10.3390/cancers10100365.

4.

Magnetic Exchange Fields and Domain Wall Superconductivity at an All-Oxide Superconductor-Ferromagnet Insulator Interface.

Komori S, Di Bernardo A, Buzdin AI, Blamire MG, Robinson JWA.

Phys Rev Lett. 2018 Aug 17;121(7):077003. doi: 10.1103/PhysRevLett.121.077003.

PMID:
30169105
5.

Temperature Controlled Fulde-Ferrell-Larkin-Ovchinnikov Instability in Superconductor-Ferromagnet Hybrids.

Mironov SV, Vodolazov DY, Yerin Y, Samokhvalov AV, Mel'nikov AS, Buzdin A.

Phys Rev Lett. 2018 Aug 17;121(7):077002. doi: 10.1103/PhysRevLett.121.077002.

PMID:
30169060
6.

Domain Meissner state and spontaneous vortex-antivortex generation in the ferromagnetic superconductor EuFe2(As0.79P0.21)2.

Stolyarov VS, Veshchunov IS, Grebenchuk SY, Baranov DS, Golovchanskiy IA, Shishkin AG, Zhou N, Shi Z, Xu X, Pyon S, Sun Y, Jiao W, Cao GH, Vinnikov LY, Golubov AA, Tamegai T, Buzdin AI, Roditchev D.

Sci Adv. 2018 Jul 13;4(7):eaat1061. doi: 10.1126/sciadv.aat1061. eCollection 2018 Jul.

7.

Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugs.

Buzdin A, Sorokin M, Garazha A, Sekacheva M, Kim E, Zhukov N, Wang Y, Li X, Kar S, Hartmann C, Samii A, Giese A, Borisov N.

Semin Cancer Biol. 2018 Dec;53:110-124. doi: 10.1016/j.semcancer.2018.06.003. Epub 2018 Jun 20. Review.

PMID:
29935311
8.

Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis.

Sarhan J, Liu BC, Muendlein HI, Weindel CG, Smirnova I, Tang AY, Ilyukha V, Sorokin M, Buzdin A, Fitzgerald KA, Poltorak A.

Cell Death Differ. 2018 May 21. doi: 10.1038/s41418-018-0122-7. [Epub ahead of print]

PMID:
29786074
9.

Correction: The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.

Kurz S, Thieme R, Amberg R, Groth M, Jahnke HG, Pieroh P, Horn LC, Kolb M, Huse K, Platzer M, Volke D, Dehghani F, Buzdin A, Engel K, Robitzki A, Hoffmann R, Gockel I, Birkenmeier G.

PLoS One. 2018 Mar 26;13(3):e0195169. doi: 10.1371/journal.pone.0195169. eCollection 2018.

10.

Profiling of Human Molecular Pathways Affected by Retrotransposons at the Level of Regulation by Transcription Factor Proteins.

Nikitin D, Penzar D, Garazha A, Sorokin M, Tkachev V, Borisov N, Poltorak A, Prassolov V, Buzdin AA.

Front Immunol. 2018 Jan 30;9:30. doi: 10.3389/fimmu.2018.00030. eCollection 2018.

11.

Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation.

Sorokin M, Kholodenko R, Grekhova A, Suntsova M, Pustovalova M, Vorobyeva N, Kholodenko I, Malakhova G, Garazha A, Nedoluzhko A, Vasilov R, Poddubskaya E, Kovalchuk O, Adamyan L, Prassolov V, Allina D, Kuzmin D, Ignatev K, Osipov A, Buzdin A.

Oncotarget. 2017 Dec 27;9(4):5111-5124. doi: 10.18632/oncotarget.23700. eCollection 2018 Jan 12.

12.

The anti-tumorigenic activity of A2M-A lesson from the naked mole-rat.

Kurz S, Thieme R, Amberg R, Groth M, Jahnke HG, Pieroh P, Horn LC, Kolb M, Huse K, Platzer M, Volke D, Dehghani F, Buzdin A, Engel K, Robitzki A, Hoffmann R, Gockel I, Birkenmeier G.

PLoS One. 2017 Dec 27;12(12):e0189514. doi: 10.1371/journal.pone.0189514. eCollection 2017. Erratum in: PLoS One. 2018 Mar 26;13(3):e0195169.

13.

A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency.

Borisov N, Tkachev V, Suntsova M, Kovalchuk O, Zhavoronkov A, Muchnik I, Buzdin A.

Cell Cycle. 2018;17(4):486-491. doi: 10.1080/15384101.2017.1417706. Epub 2018 Jan 17.

PMID:
29251172
14.

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas.

Petrov I, Suntsova M, Ilnitskaya E, Roumiantsev S, Sorokin M, Garazha A, Spirin P, Lebedev T, Gaifullin N, Larin S, Kovalchuk O, Konovalov D, Prassolov V, Roumiantsev A, Buzdin A.

Oncotarget. 2017 Jul 28;8(48):83768-83780. doi: 10.18632/oncotarget.19662. eCollection 2017 Oct 13.

15.

Potentialities of MicroRNA Diagnosis in Patients with Bladder Cancer.

Shegay PV, Zhavoronkov AA, Gaifullin NM, Vorob'ev NV, Alekseev BY, Popov SV, Garazha AV, Buzdin AA, Kaprin AD.

Bull Exp Biol Med. 2017 Nov;164(1):106-108. doi: 10.1007/s10517-017-3935-3. Epub 2017 Nov 9.

PMID:
29119388
16.

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

Spirin P, Lebedev T, Orlova N, Morozov A, Poymenova N, Dmitriev SE, Buzdin A, Stocking C, Kovalchuk O, Prassolov V.

Oncotarget. 2017 Jun 16;8(34):56991-57002. doi: 10.18632/oncotarget.18503. eCollection 2017 Aug 22.

17.

Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.

Buzdin AA, Prassolov V, Zhavoronkov AA, Borisov NM.

Methods Mol Biol. 2017;1613:53-83. doi: 10.1007/978-1-4939-7027-8_4.

PMID:
28849558
18.

Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).

Aliper AM, Korzinkin MB, Kuzmina NB, Zenin AA, Venkova LS, Smirnov PY, Zhavoronkov AA, Buzdin AA, Borisov NM.

Methods Mol Biol. 2017;1613:31-51. doi: 10.1007/978-1-4939-7027-8_3.

PMID:
28849557
19.

Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data.

Borisov N, Suntsova M, Sorokin M, Garazha A, Kovalchuk O, Aliper A, Ilnitskaya E, Lezhnina K, Korzinkin M, Tkachev V, Saenko V, Saenko Y, Sokov DG, Gaifullin NM, Kashintsev K, Shirokorad V, Shabalina I, Zhavoronkov A, Mishra B, Cantor CR, Buzdin A.

Cell Cycle. 2017 Oct 2;16(19):1810-1823. doi: 10.1080/15384101.2017.1361068. Epub 2017 Aug 21.

20.

Friends-Enemies: Endogenous Retroviruses Are Major Transcriptional Regulators of Human DNA.

Buzdin AA, Prassolov V, Garazha AV.

Front Chem. 2017 Jun 8;5:35. doi: 10.3389/fchem.2017.00035. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center